Immunology

  1. Structure of a germline-like human antibody defines a neutralizing epitope on the SARS-CoV-2 spike NTD

    1. Clara G. Altomare
    2. Daniel C. Adelsberg
    3. Juan Manuel Carreno
    4. Iden A. Sapse
    5. Fatima Amanat
    6. Ali H. Ellebedy
    7. Viviana Simon
    8. Florian Krammer
    9. Goran Bajic

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions

    1. Mai M. Abdelmoaty
    2. Pravin Yeapuri
    3. Jatin Machhi
    4. Katherine E. Olson
    5. Farah Shahjin
    6. Vikas Kumar
    7. You Zhou
    8. Jingjing Liang
    9. Kabita Pandey
    10. Arpan Acharya
    11. Siddappa N. Byrareddy
    12. R. Lee Mosley
    13. Howard E. Gendelman

    Reviewed by ScreenIT

    1 evaluationAppears in 4 listsLatest version Latest activity

  3. Antibody and T cell memory immune response after two doses of the BNT162b2 mRNA vaccine in older adults with and without prior SARS-CoV-2 infection

    1. Julie Demaret
    2. Bénédicte Corroyer-Simovic
    3. Enagnon Kazali Alidjinou
    4. Anne Goffard
    5. Jacques Trauet
    6. Sophie Miczek
    7. Fanny Vuotto
    8. Arnaud Dendooven
    9. Dominique Huvent-Grelle
    10. Juliette Podvin
    11. Daniel Dreuil
    12. Karine Faure
    13. Dominique Deplanque
    14. Laurence Bocket
    15. Alain Duhamel
    16. Julien Labreuche
    17. Annie Sobaszek
    18. Francois Puisieux
    19. Myriam Labalette
    20. Guillaume Lefèvre

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. A Newcastle disease virus-vector expressing a prefusion-stabilized spike protein of SARS-CoV-2 induces protective immune responses against prototype virus and variants of concern in mice and hamsters

    1. Weina Sun
    2. Yonghong Liu
    3. Fatima Amanat
    4. Irene González-Domínguez
    5. Stephen McCroskery
    6. Stefan Slamanig
    7. Lynda Coughlan
    8. Victoria Rosado
    9. Nicholas Lemus
    10. Sonia Jangra
    11. Raveen Rathnasinghe
    12. Michael Schotsaert
    13. Jose Martinez
    14. Kaori Sano
    15. Ignacio Mena
    16. Bruce L Innis
    17. Ponthip Wirachwong
    18. Duong Huu Thai
    19. Ricardo Das Neves Oliveira
    20. Rami Scharf
    21. Richard Hjorth
    22. Rama Raghunandan
    23. Florian Krammer
    24. Adolfo García-Sastre
    25. Peter Palese

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. An autoantigen profile from Jurkat T-Lymphoblasts provides a molecular guide for investigating autoimmune sequelae of COVID-19

    1. Julia Y. Wang
    2. Wei Zhang
    3. Michael W. Roehrl
    4. Victor B. Roehrl
    5. Michael H. Roehrl

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Predicted impact of the viral mutational landscape on the cytotoxic response against SARS-CoV-2

    1. Anna Foix
    2. Daniel López
    3. Francisco Díez-Fuertes
    4. Michael J. McConnell
    5. Antonio J. Martín-Galiano

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection

    1. Lei Li
    2. Yoshikazu Honda-Okubo
    3. Ying Huang
    4. Hyesun Jang
    5. Michael A. Carlock
    6. Jeremy Baldwin
    7. Sakshi Piplani
    8. Anne G. Bebin-Blackwell
    9. David Forgacs
    10. Kaori Sakamoto
    11. Alberto Stella
    12. Stuart Turville
    13. Tim Chataway
    14. Alex Colella
    15. Jamie Triccas
    16. Ted M. Ross
    17. Nikolai Petrovsky

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. SARS-CoV-2 Lambda Variant Remains Susceptible to Neutralization by mRNA Vaccine-elicited Antibodies and Convalescent Serum

    1. Takuya Tada
    2. Hao Zhou
    3. Belinda M. Dcosta
    4. Marie I. Samanovic
    5. Mark J. Mulligan
    6. Nathaniel R. Landau

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Ad26.COV2.S elicited neutralizing activity against Delta and other SARS-CoV-2 variants of concern

    1. Mandy Jongeneelen
    2. Krisztian Kaszas
    3. Daniel Veldman
    4. Jeroen Huizingh
    5. Remko van der Vlugt
    6. Theo Schouten
    7. David Zuijdgeest
    8. Taco Uil
    9. Griet van Roey
    10. Nuria Guimera
    11. Marjon Navis
    12. Rinke Bos
    13. Mathieu le Gars
    14. Jerald Sadoff
    15. Leacky Muchene
    16. Jarek Juraszek
    17. Johannes PM Langedijk
    18. Ronald Vogels
    19. Jerome Custers
    20. Hanneke Schuitemaker
    21. Boerries Brandenburg

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples

    1. Sasha E. Larsen
    2. Bryan J. Berube
    3. Tiffany Pecor
    4. Evan Cross
    5. Bryan P. Brown
    6. Brittany D. Williams
    7. Emma Johnson
    8. Pingping Qu
    9. Lauren Carter
    10. Samuel Wrenn
    11. Elizabeth Kepl
    12. Claire Sydeman
    13. Neil P. King
    14. Susan L. Baldwin
    15. Rhea N. Coler

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 105 of 174 Next